Immune and inflammatory pathway proteins

Immune and inflammatory pathway proteins represent a broad and diverse class of molecules that orchestrate the body's response to injury, infection, and foreign substances. This category encompasses various functional groups, including cytokines, chemokines, cell surface receptors, and intracellular signaling molecules like Janus kinases (Source: Nature Reviews Immunology). These proteins are essential for maintaining homeostasis and mounting an effective defense, but their chronic or excessive activation is a primary driver of autoimmune and autoinflammatory diseases (Source: StatPearls, Inflammation). Because this term describes a functional network rather than a single molecular entity, it is considered a category of targets rather than a specific therapeutic target itself. Drugs targeting these pathways, such as monoclonal antibodies against Tumor necrosis factor-alpha or small molecule inhibitors of Janus kinase enzymes, are cornerstones in treating conditions like rheumatoid arthritis and psoriasis (Source: NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases). Therapeutic intervention requires precise targeting to balance the reduction of harmful inflammation with the preservation of necessary immune surveillance. Common biomarkers used to monitor the activity of these pathway proteins include C-reactive protein and specific cytokine levels (Source: PubMed, PMID: 29461141).

Other names

Inflammatory mediatorsImmune signaling proteinsCytokines and chemokinesImmunomodulatory proteins

Modulation of immune signaling through the inhibition of specific cytokines, receptors, or intracellular signaling enzymes to reduce pathological inflammation.